{"id":"matching-placebo-capsules","safety":{"commonSideEffects":[]},"_chembl":null,"_fixedAt":"2026-03-30T17:15:05.246092","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo capsules serve as the control arm in randomized controlled trials, allowing researchers to isolate the true pharmacological effect of an investigational drug from placebo response and natural disease progression. By matching the active drug in appearance, taste, and administration route, placebo capsules enable double-blind study design where neither participants nor some study staff know treatment assignment, reducing bias.","oneSentence":"Matching placebo capsules contain inert ingredients designed to mimic the appearance and administration of an active pharmaceutical agent for blinded clinical trial control.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:20:15.174Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"_fixedFields":["pubmed(53)"],"trialDetails":[{"nctId":"NCT07135232","phase":"NA","title":"The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2026-03-01","conditions":"Perimenopause, Menopause","enrollment":72},{"nctId":"NCT06898606","phase":"PHASE1, PHASE2","title":"Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression","status":"RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2024-09-05","conditions":"Depressive Disorder","enrollment":24},{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT06631287","phase":"PHASE3","title":"Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID","status":"RECRUITING","sponsor":"Wes Ely","startDate":"2024-10-21","conditions":"Long COVID, Sars-CoV-2 Infection, Coronavirus Infections","enrollment":550},{"nctId":"NCT06072183","phase":"PHASE3","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-11-08","conditions":"Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo","enrollment":1571},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT06450366","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Hypercholesterolemia","enrollment":301},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07495592","phase":"NA","title":"The Acute Effects of Onnit Alpha Brain on Cognition and Mood States","status":"NOT_YET_RECRUITING","sponsor":"Applied Science & Performance Institute","startDate":"2026-04-16","conditions":"Cognitive, Mood and Cognitive Performance, Sleep Deprivation","enrollment":34},{"nctId":"NCT07332091","phase":"PHASE2","title":"Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2026-01-22","conditions":"Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis","enrollment":84},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT04801849","phase":"PHASE2","title":"Vitamin E Dosing Study","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-08-05","conditions":"Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis","enrollment":200},{"nctId":"NCT07209462","phase":"PHASE2","title":"Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)","status":"RECRUITING","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2025-11-22","conditions":"Fragile X Syndrome","enrollment":60},{"nctId":"NCT07474831","phase":"NA","title":"Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-23","conditions":"Recurrent Bacterial Vaginosis","enrollment":156},{"nctId":"NCT07144293","phase":"PHASE2","title":"Improving Physical Ability and Cellular Senescence Elimination in HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-04","conditions":"HIV, Frailty, Prefrail","enrollment":82},{"nctId":"NCT06006559","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-20","conditions":"Dengue","enrollment":108},{"nctId":"NCT07065240","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)","status":"RECRUITING","sponsor":"Seaport Therapeutics","startDate":"2025-06-19","conditions":"Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress","enrollment":360},{"nctId":"NCT07300514","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Maintenance Treatment of Peripheral T-cell Lymphoma","enrollment":136},{"nctId":"NCT05677763","phase":"PHASE4","title":"OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness","status":"ACTIVE_NOT_RECRUITING","sponsor":"OM Pharma SA","startDate":"2022-12-12","conditions":"Respiratory Tract Infections, Wheezing Lower Respiratory Illness","enrollment":525},{"nctId":"NCT07325266","phase":"PHASE2","title":"Human Laboratory Study of Apremilast for Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2026-04-01","conditions":"Alcohol Use Disorder, Alcohol Misuse","enrollment":100},{"nctId":"NCT06948214","phase":"PHASE3","title":"Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency","status":"RECRUITING","sponsor":"Lumos Pharma","startDate":"2026-04","conditions":"Growth Hormone Deficiency (GHD)","enrollment":150},{"nctId":"NCT06934915","phase":"EARLY_PHASE1","title":"Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Christopher John McDougle, M.D.","startDate":"2026-11","conditions":"Autism Spectrum Disorder, Autism Spectrum Disorders, Autistic Disorder","enrollment":32},{"nctId":"NCT07487909","phase":"PHASE1, PHASE2","title":"A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol","status":"COMPLETED","sponsor":"Sen-Jam Pharmaceutical","startDate":"2025-09-30","conditions":"Healthy","enrollment":47},{"nctId":"NCT05364008","phase":"PHASE3","title":"FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-01-05","conditions":"Leiomyoma, Uterine","enrollment":33},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT07216482","phase":"PHASE3","title":"A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-11","conditions":"Hyperlipidemia","enrollment":975},{"nctId":"NCT03970720","phase":"PHASE2","title":"Restoration of Hypoglycemia Awareness With Metoclopramide","status":"RECRUITING","sponsor":"Simon Fisher","startDate":"2019-05-28","conditions":"Hypoglycemia Unawareness","enrollment":36},{"nctId":"NCT06517758","phase":"PHASE3","title":"A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-31","conditions":"Generalized Myasthenia Gravis","enrollment":146},{"nctId":"NCT07310264","phase":"PHASE1","title":"Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease","status":"RECRUITING","sponsor":"Vertero Therapeutics","startDate":"2025-10-30","conditions":"Healthy Volunteers (HV), Parkinson's Disease (PD)","enrollment":84},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT07484412","phase":"NA","title":"Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2025-08-01","conditions":"Lower Abdominal Pain, Diarrhea, Irritable Bowel Syndrome","enrollment":88},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT06307652","phase":"PHASE3","title":"Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-12","conditions":"Heart Failure and Impaired Kidney Function","enrollment":4800},{"nctId":"NCT07483632","phase":"PHASE3","title":"A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-11-16","conditions":"Relapsing Forms of Multiple Sclerosis","enrollment":185},{"nctId":"NCT04614714","phase":"PHASE2, PHASE3","title":"Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-04-01","conditions":"Preterm Birth, Inadequate Milk Production","enrollment":40},{"nctId":"NCT07482644","phase":"NA","title":"Efficacy and Safety of an Essential Oil-Based Product System for Immune Support","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-05-04","conditions":"Immune System Function, Inflammation","enrollment":40},{"nctId":"NCT07481981","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)","status":"NOT_YET_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2026-04-17","conditions":"Pulmonary Arterial Hypertension","enrollment":344},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT07181382","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"SUSPENDED","sponsor":"GB002, Inc.","startDate":"2026-02","conditions":"Pulmonary Hypertension Associated With Interstitial Lung Disease","enrollment":480},{"nctId":"NCT07479173","phase":"NA","title":"Effects of P24 on Postprandial Aminoacidemia","status":"NOT_YET_RECRUITING","sponsor":"Amplifye","startDate":"2026-05-01","conditions":"Postprandial Amino Acid Concentrations in Healthy Adults","enrollment":30},{"nctId":"NCT05934526","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)","status":"COMPLETED","sponsor":"GB002, Inc.","startDate":"2023-12-28","conditions":"Pulmonary Arterial Hypertension","enrollment":390},{"nctId":"NCT02947347","phase":"PHASE3","title":"Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma","status":"COMPLETED","sponsor":"Pharmacyclics LLC.","startDate":"2017-01-23","conditions":"Follicular Lymphoma","enrollment":445},{"nctId":"NCT05741710","phase":"PHASE1, PHASE2","title":"A Study to Assess the Use of Methylone in the Treatment of PTSD","status":"COMPLETED","sponsor":"Transcend Therapeutics","startDate":"2023-03-01","conditions":"Post Traumatic Stress Disorder","enrollment":79},{"nctId":"NCT07288138","phase":"PHASE2","title":"A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Eccogene","startDate":"2025-12-15","conditions":"Metabolic Dysfunction-associated Steatohepatitis","enrollment":160},{"nctId":"NCT05396105","phase":"PHASE2, PHASE3","title":"Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema","status":"ENROLLING_BY_INVITATION","sponsor":"Pharvaris Netherlands B.V.","startDate":"2022-12-28","conditions":"Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II","enrollment":150},{"nctId":"NCT07151261","phase":"NA","title":"Ashwagandha for Nighttime Waking","status":"ACTIVE_NOT_RECRUITING","sponsor":"National University of Natural Medicine","startDate":"2025-10-20","conditions":"Disturbed Sleep","enrollment":54},{"nctId":"NCT06619860","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-18","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":300},{"nctId":"NCT03748641","phase":"PHASE3","title":"A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-01-25","conditions":"Castration-Resistant Prostatic Cancer","enrollment":765},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT05757869","phase":"PHASE3","title":"A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-11","conditions":"Atrial Fibrillation","enrollment":20284},{"nctId":"NCT06454669","phase":"PHASE2","title":"Dronabinol as an Adjunct for Reducing Pain","status":"RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2024-06-15","conditions":"Low Back Pain, Chronic Pain, Back Injuries","enrollment":75},{"nctId":"NCT07218549","phase":"PHASE1","title":"Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use","status":"NOT_YET_RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2026-05-01","conditions":"Opioid Use, Substance Use Disorders, Opioid Analgesia","enrollment":72},{"nctId":"NCT05523323","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-10-30","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":112},{"nctId":"NCT06834997","phase":"PHASE2","title":"Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2026-04-01","conditions":"Endometriosis, Endometriosis Related Pain, Endometriosis, Pain","enrollment":""},{"nctId":"NCT05138822","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-05-18","conditions":"Uncomplicated Urinary Tract Infections, Urinary Tract Infections","enrollment":140},{"nctId":"NCT06511063","phase":"PHASE2","title":"Antiviral Clinical Trial for Long Covid-19","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-10-01","conditions":"Long Covid","enrollment":90},{"nctId":"NCT07108283","phase":"PHASE2","title":"A Study of Zasocitinib in Adults With Nonsegmental Vitiligo","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-11-03","conditions":"Nonsegmental Vitiligo","enrollment":200},{"nctId":"NCT06254950","phase":"PHASE2","title":"A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-03-29","conditions":"Ulcerative Colitis","enrollment":207},{"nctId":"NCT07452744","phase":"NA","title":"Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Bioagile Therapeutics Pvt. Ltd.","startDate":"2024-08-13","conditions":"Non Alcholic Fatty Liver Disease","enrollment":170},{"nctId":"NCT07260669","phase":"PHASE2","title":"A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis","status":"RECRUITING","sponsor":"Gesynta Pharma AB","startDate":"2025-10-15","conditions":"Endometriosis","enrollment":190},{"nctId":"NCT04192136","phase":"NA","title":"NAD+ and Exercise in FA","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-09-03","conditions":"Friedreich Ataxia 1","enrollment":75},{"nctId":"NCT07145658","phase":"NA","title":"Multivitamin for Health and Cognition","status":"COMPLETED","sponsor":"Dr Anthony Hobson","startDate":"2025-07-07","conditions":"Healthy, Cognition, Health","enrollment":37},{"nctId":"NCT07463196","phase":"PHASE1","title":"A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants","status":"RECRUITING","sponsor":"AC Immune SA","startDate":"2026-01-28","conditions":"Healthy Participants","enrollment":78},{"nctId":"NCT07052890","phase":"NA","title":"Curcumin, Vitamin D and Green Tea in IBS-D","status":"COMPLETED","sponsor":"Dr Anthony Hobson","startDate":"2024-09-19","conditions":"Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome With Diarrhea (IBS-D)","enrollment":78},{"nctId":"NCT05869643","phase":"PHASE2","title":"A Clinical Trial of STP0404 in Adults With HIV-1 Infection","status":"RECRUITING","sponsor":"ST Pharm Co., Ltd.","startDate":"2023-05-23","conditions":"HIV-1-infection","enrollment":36},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT07461402","phase":"NA","title":"Plant Protein With Ashwagandha-Rhodiola for Sleep Quality","status":"COMPLETED","sponsor":"Universidad Pablo de Olavide","startDate":"2025-11-01","conditions":"Sleep Quality, Sleep Disorders, Insomnia","enrollment":100},{"nctId":"NCT07462780","phase":"PHASE1","title":"A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Kangzhe Biotechnology Co., Ltd.","startDate":"2026-03","conditions":"Paroxysmal Nocturnal Hemoglobinuria, PNH, Complement-mediated Kidney Disease","enrollment":88},{"nctId":"NCT07193563","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of ENX-102 in Participants With Social Anxiety Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Engrail Therapeutics INC","startDate":"2025-09-05","conditions":"Social Anxiety Disorder (SAD)","enrollment":47},{"nctId":"NCT07459829","phase":"PHASE2","title":"Study of CU06-1004 in Patients With Daibetic Macular Edema","status":"NOT_YET_RECRUITING","sponsor":"Curacle Co., Ltd.","startDate":"2026-12-01","conditions":"DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)","enrollment":156},{"nctId":"NCT05147220","phase":"PHASE3","title":"Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2021-12-16","conditions":"Relapsing Multiple Sclerosis","enrollment":1001},{"nctId":"NCT06043830","phase":"PHASE2","title":"Managing Opioid Related Sleep Apnea With Acetazolamide","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2023-10-18","conditions":"Sleep-Disordered Breathing, Obstructive Sleep Apnea, Central Sleep Apnea","enrollment":39},{"nctId":"NCT07453212","phase":"NA","title":"Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction","status":"ENROLLING_BY_INVITATION","sponsor":"Varol TUNALI","startDate":"2026-03-01","conditions":"Dry Eye, Evaporative Dry Eye Disease, Meibomian Gland Dysfunction (Disorder)","enrollment":130},{"nctId":"NCT05730283","phase":"PHASE2","title":"Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin","status":"RECRUITING","sponsor":"Kevin Winthrop","startDate":"2025-06-02","conditions":"Ototoxicity, Drug-Induced","enrollment":105},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT06315751","phase":"PHASE2","title":"Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Noema Pharma AG","startDate":"2024-09-10","conditions":"Tourette Syndrome","enrollment":164},{"nctId":"NCT06671483","phase":"PHASE3","title":"A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-03-03","conditions":"Psoriatic Arthritis","enrollment":1088},{"nctId":"NCT06638502","phase":"PHASE1, PHASE2","title":"Safety of HRX215 in Patients After Minor and Major Liver Resection","status":"RECRUITING","sponsor":"HepaRegeniX GmbH","startDate":"2025-05-06","conditions":"Colorectal Liver Metastases, Liver Resection","enrollment":25},{"nctId":"NCT07140874","phase":"PHASE2","title":"Zinc as an Adjunctive Therapy for Cervical Dystonia","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-02-20","conditions":"Cervical Dystonia","enrollment":20},{"nctId":"NCT05986318","phase":"PHASE2","title":"Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease","status":"RECRUITING","sponsor":"David Palma","startDate":"2025-01-07","conditions":"Lung Cancer, Interstitial Lung Disease","enrollment":98},{"nctId":"NCT07458594","phase":"NA","title":"Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2025-10-30","conditions":"Aerial Duel Performance in Soccer Players","enrollment":96},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07456176","phase":"PHASE3","title":"Effect of Low-Dose Versus High-Dose Alpha-Lipoic Acid on Oxidative Stress, Inflammation, and Clinical Outcomes in Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-02-28","conditions":"Acute Exacerbation Chronic Obstructive Pulmonary Disease","enrollment":75},{"nctId":"NCT04057898","phase":"PHASE2, PHASE3","title":"Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"MediciNova","startDate":"2020-05-28","conditions":"Amyotrophic Lateral Sclerosis","enrollment":234},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT07452562","phase":"NA","title":"Hesperidin RCT in MS","status":"RECRUITING","sponsor":"Swansea University","startDate":"2026-01-07","conditions":"Multiple Sclerosis","enrollment":60},{"nctId":"NCT05571059","phase":"PHASE2","title":"Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)","status":"RECRUITING","sponsor":"Cumberland Pharmaceuticals","startDate":"2024-01-31","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":128},{"nctId":"NCT07298395","phase":"PHASE2","title":"Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2025-12-22","conditions":"Atopic Dermatitis (AD)","enrollment":64},{"nctId":"NCT07301255","phase":"PHASE2","title":"ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2026-01-09","conditions":"Asthma","enrollment":50},{"nctId":"NCT07451639","phase":"NA","title":"Effect of a Reducose®-Based Supplement on Metabolic Health in Subjects With Metabolic Syndrome","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo","startDate":"2023-03-01","conditions":"Weight Management","enrollment":50},{"nctId":"NCT07449351","phase":"EARLY_PHASE1","title":"Psilocybin Microdosing on Cognition, Mood and Quality of Life","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-04-01","conditions":"Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI","enrollment":20},{"nctId":"NCT07179380","phase":"PHASE3","title":"Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"RECRUITING","sponsor":"Insmed Incorporated","startDate":"2026-01-07","conditions":"Pulmonary Hypertension, Interstitial Lung Disease","enrollment":344},{"nctId":"NCT05407324","phase":"PHASE2","title":"Dazucorilant in Patients With Amyotrophic Lateral Sclerosis","status":"RECRUITING","sponsor":"Corcept Therapeutics","startDate":"2022-11-15","conditions":"Amyotrophic Lateral Sclerosis","enrollment":279},{"nctId":"NCT05050136","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis","status":"RECRUITING","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2021-09-22","conditions":"Primary Biliary Cholangitis, PBC","enrollment":260},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT04336722","phase":"PHASE3","title":"Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Albireo, an Ipsen Company","startDate":"2020-07-08","conditions":"Biliary Atresia","enrollment":254},{"nctId":"NCT07444138","phase":"NA","title":"Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women","status":"RECRUITING","sponsor":"São Paulo State University","startDate":"2025-10-08","conditions":"Hypertension, Hypertension (HTN)","enrollment":20},{"nctId":"NCT05428033","phase":"PHASE3","title":"A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-07-11","conditions":"Attention Deficit/Hyperactivity Disorder","enrollment":574},{"nctId":"NCT06568237","phase":"PHASE2","title":"A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy","status":"RECRUITING","sponsor":"Teva Branded Pharmaceutical Products R&D LLC","startDate":"2024-10-02","conditions":"Multiple System Atrophy","enrollment":350}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":53,"recentPublications":[{"date":"2025 Feb","pmid":"39873544","title":"Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.","journal":"NEJM evidence"},{"date":"2024","pmid":"38706271","title":"Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies.","journal":"The journal of prevention of Alzheimer's disease"},{"date":"2022 Sep 21","pmid":"36130946","title":"Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration.","journal":"Nature communications"},{"date":"2022 Oct","pmid":"36087590","title":"Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.","journal":"The Lancet. Oncology"},{"date":"2022 Dec","pmid":"35863457","title":"Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.","journal":"American journal of obstetrics and gynecology"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Matching placebo capsules","genericName":"Matching placebo capsules","companyName":"Nanjing Medical University","companyId":"nanjing-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}